
Doximity, Inc.
- Jurisdiction
United States - ISIN
US26622P1075 (DOCS )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€22.68 ∞% undervalued - Financial strength (Piotroski F-Value)
-
7
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. Read full profile
Fundamentals
- Net revenue
€502.93M - Gross margin
90.1% - EBIT
€201.52M - EBIT margin
40.1% - Net income
€200.55M - Net margin
39.9%
Statement period: - (published )
Estimates
Fiscal Year | Net revenue | Net income |
---|---|---|
| N/A | |
| N/A | |
| N/A |
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
Name | Title | Transaction Date | Shares | Price | Value |
---|---|---|---|---|---|
Cabral Timothy S | N/A |
|
|
|
|
Wampler Kira Scherer | N/A |
|
|
|
|
Bryson Anna | Chief Financial Officer |
|
|
|
|
Cabral Timothy S | N/A |
|
|
|
|
Benjamin Regina M. | N/A |
|
|
|
|
Congress transactions
Name | Transaction date | Value |
---|---|---|
Jonathan Jackson | September 23, 2025 | $15.00K–$50.00K |
Earnings Calls
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
James Anderson |
|
|
|
Sell |
Peter Brown |
|
|
|
Buy |
Terry Smith |
|
|
|
Buy |
Earnings Calls
Latest earnings call: May 16, 2024 (Q4 2024)